Clinical Trial Update: National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Evaluating Mesenchymal Stem-Cell (MSC) Therapy in Non-viral Acute on Chronic Liver Failure (ACLF) Patients - Phase-III Trial [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating mesenchymal stem-cell therapy for acute-on-chronic liver failure (ACLF) due to non-viral causes, sponsored by the Institute …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• On Chronic Liver Failure

Drugs mentioned

• Mesenchymal stem cell therapy (mesenchymal stem cells)

Snippet

Sponsor: Institute of Liver and Biliary Sciences, India | Conditions: Acute-On-Chronic Liver Failure | Phase 3 | Status: NOT_YET_RECRUITING